Work

Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder

Year: 2013

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Neuropsychopharmacology

DOI: 10.1038/npp.2013.334

Authors: Manisha Madhoo, Richard SE Keefe, Robert M Roth, Angelo Sambunaris, James Wu, Madhukar H Trivedi, Colleen S Anderson, Robert Lasser

Institutions: Duke Medical Center, Dartmouth College, Institute for Advanced Medical Research, The University of Texas Southwestern Medical Center, F. Hoffmann-La Roche AG

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Veterans Affairs, Abbott Laboratories, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, CeNeRx, F. Hoffmann-La Roche, Sunovion, Mylan, Astellas Pharma, H. Lundbeck A/S, Agency for Healthcare Research and Quality, Medical Research Council, National Medical Research Council, National Institute of Mental Health

OpenAlex ID: W2079804712

FWCI: 7.523

Cites: 46

Cited by: 75

Related to: 10